- Filed
- Feb 26, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Jan 31, 2025 | 50.07M sh |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $442.63M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $139.02M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $228.16M |
| Current Assets | FY 2024 · Dec 31, 2023 | $528.82M |
| Total Assets | FY 2024 · Dec 31, 2023 | $597M |
| Shares Diluted | FY 2024 · Dec 31, 2022 | 45.71M sh |
| Capex | FY 2024 · Dec 31, 2022 | $2.2M |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | −$49.21M |
| Eps Diluted | FY 2024 · Dec 31, 2022 | −$1.15 |
| Eps Basic | FY 2024 · Dec 31, 2022 | −$1.15 |
| Sga Expense | FY 2024 · Dec 31, 2022 | $123.06M |
| Rd Expense | FY 2024 · Dec 31, 2022 | $101.92M |
| Net Income | FY 2024 · Dec 31, 2022 | −$52.54M |
| Operating Income | FY 2024 · Dec 31, 2022 | −$51.71M |
| Cost Of Revenue | FY 2024 · Dec 31, 2022 | $1.09M |
| Revenue restated | FY 2024 · Dec 31, 2022 | $174.36M |
| Stockholders Equity | FY 2024 · Dec 31, 2021 | $233.71M |